AU5415699A - Water-soluble pharmaceutical formulation for administering sildenafil - Google Patents

Water-soluble pharmaceutical formulation for administering sildenafil

Info

Publication number
AU5415699A
AU5415699A AU54156/99A AU5415699A AU5415699A AU 5415699 A AU5415699 A AU 5415699A AU 54156/99 A AU54156/99 A AU 54156/99A AU 5415699 A AU5415699 A AU 5415699A AU 5415699 A AU5415699 A AU 5415699A
Authority
AU
Australia
Prior art keywords
water
pharmaceutical formulation
soluble pharmaceutical
sildenafil
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54156/99A
Inventor
Thomas Strungmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU5415699A publication Critical patent/AU5415699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
AU54156/99A 1998-07-31 1999-07-30 Water-soluble pharmaceutical formulation for administering sildenafil Abandoned AU5415699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19834507A DE19834507A1 (en) 1998-07-31 1998-07-31 Pharmaceutical, water-soluble tablet formulation for the use of sildenafil
DE19834507 1998-07-31
PCT/EP1999/005464 WO2000007596A1 (en) 1998-07-31 1999-07-30 Water-soluble pharmaceutical formulation for administering sildenafil

Publications (1)

Publication Number Publication Date
AU5415699A true AU5415699A (en) 2000-02-28

Family

ID=7875941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54156/99A Abandoned AU5415699A (en) 1998-07-31 1999-07-30 Water-soluble pharmaceutical formulation for administering sildenafil

Country Status (3)

Country Link
AU (1) AU5415699A (en)
DE (1) DE19834507A1 (en)
WO (1) WO2000007596A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
BRPI0003386B8 (en) 2000-08-08 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda homo- or heterodimeric prodrugs useful in treating diseases or disorders mediated by phosphodiesterases; pharmaceutical compositions containing the prodrug or its pharmaceutical acceptable salts; process of obtaining these prodrugs
US20050143388A1 (en) * 2002-01-04 2005-06-30 Michael Chopp Nitric oxide donors for treatment of disease and injury
KR100435514B1 (en) * 2002-03-22 2004-06-10 한미약품 주식회사 Fast dissolving formulation of sildenafil lactate
GB0219516D0 (en) * 2002-08-21 2002-10-02 Phoqus Ltd Fast dissolving and taste masked oral dosage form comprising sildenafil
GB0606234D0 (en) * 2006-03-29 2006-05-10 Pliva Istrazivanje I Razvoj D Pharmaceutically acceptable salts and polymorphic forms
FR3013221B1 (en) * 2013-11-19 2020-11-27 Nabil Said EFFERVESCENT PHARMACEUTICAL COMPOSITION BASED ON SILDENAFIL AND ITS MANUFACTURING PROCESS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
WO1998030209A1 (en) * 1997-01-06 1998-07-16 Pfizer Pharmaceuticals Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
JPH10298062A (en) * 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd Rapidly dissolving type tablet in oral cavity
JP4588809B2 (en) * 1997-05-19 2010-12-01 リプロス セラピューティクス インコーポレイテッド Combination therapy to modulate human sexual response
AR017694A1 (en) * 1997-12-02 2001-09-12 West Christopher A COMPOSITION FOR THE NASAL ADMINISTRATION OF A PHARMACO TO TREAT ERECTILE DYSFUNCTION, THE USE OF SUCH COMPOSITION IN THE MANUFACTURE OF A MEDICINAL PRODUCT, AND A PROCEDURE FOR THE PREPARATION OF COMPOSITION
GB9726343D0 (en) * 1997-12-13 1998-02-11 Auffret Anthony The use of excipients to accelerate freeze-drying
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury

Also Published As

Publication number Publication date
WO2000007596A1 (en) 2000-02-17
DE19834507A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
AU2331801A (en) Improved pharmaceutical compositions for poorly soluble drugs
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU7375598A (en) Stable oral pharmaceutical dosage forms
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU4328800A (en) Pharmaceutical formulation
AU1827799A (en) Oral delivery formulation
AU2001284444A1 (en) Preparations for oral administration
AU6715600A (en) Pharmaceutical formulations
AU5838398A (en) Rapamycin formulations for oral administration
AU2564399A (en) Isoflavanoid formulations for oral administration
AU5415699A (en) Water-soluble pharmaceutical formulation for administering sildenafil
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU3055099A (en) A pharmaceutical formulation for nasal administration
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
GB9818927D0 (en) Pharmaceutical formulation
AU1688099A (en) Pharmaceutical preparation
AU3839900A (en) Pharmaceutical formulation
AU2870899A (en) Oral formulation for hydrophilic drugs
AU5182099A (en) Pharmaceutical formulation
AU1304601A (en) Solid preparations for oral use
AU6473699A (en) Aqueous drug formulation for oral application
AU1388501A (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
AU3860797A (en) Pharmaceutical formulations for oral administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase